Ras inhibitors

Ras inhibitors has been studied in 3 papers since 2024: 1 observational study in people, 2 reviews; 2 in the past year. The newest paper, Oct 26, 2026: “Temporal trends in incident heart failure medication use and clinical characteristics across guideline eras: a retrospective cohort study”.

Intervention

3 papers study it2 findingsUpdated

1 new paper in 30 daysSee all 3 papers on ras inhibitors

  • Humans1

What did studies of ras inhibitors find?

1

Studies of ras inhibitors measured one outcome, chronic kidney disease.

Chronic kidney disease

downin humans1

1 study
  1. Ras inhibitors decrease chronic kidney disease in four-pillar pharmacotherapy.

    “When tailored to the degree of albuminuria and eGFR, this treatment significantly slows the progression of chronic kidney disease and reduces cardiovascular risk.”

    Reviewin four-pillar pharmacotherapykidney

    Albuminuria for detection of chronic kidney disease: biomarker and therapeutic target

    Orvosi hetilap

More on Chronic kidney disease

What is ras inhibitors linked with?

1

Studies link ras inhibitors with muscle strength.

Muscle strength

mixedin reviews1

1 study
  1. Ras inhibitors are associated with muscle strength.

    “effects of the use of RAS inhibitors on muscle strength”

    Review

    Muscle mass, muscle strength and the renin-angiotensin system

    Clinical science (London, England : 1979)

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 0Oct 2026: 1Nov 2026: 02 papers in 12 months